000			01984 a2200589 4500
005			20250514225906.0
264		0	_c20050715
008			200507s 0 0 eng d
022			_a0014-4886
024	7		_a10.1016/j.expneurol.2005.02.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aChang-Hong, Ren
245	0	0	_aNeuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis. _h[electronic resource]
260			_bExperimental neurology _cJul 2005
300			_a203-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAge of Onset
650	0	4	_aAmino Acid Substitution _xgenetics
650	0	4	_aAmyotrophic Lateral Sclerosis _xgenetics
650	0	4	_aAnimals
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDisease Progression
650	0	4	_aGalectin 1 _xmetabolism
650	0	4	_aHumans
650	0	4	_aInclusion Bodies _xgenetics
650	0	4	_aInjections, Intramuscular
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aMotor Neurons _xmetabolism
650	0	4	_aMutation _xgenetics
650	0	4	_aNeurofilament Proteins _xmetabolism
650	0	4	_aNeuroprotective Agents _xmetabolism
650	0	4	_aOxidation-Reduction
650	0	4	_aSpinal Cord _xmetabolism
650	0	4	_aSuperoxide Dismutase _xgenetics
650	0	4	_aSuperoxide Dismutase-1
650	0	4	_aSurvival Rate
650	0	4	_aTreatment Outcome
700	1		_aWada, Manabu
700	1		_aKoyama, Shingo
700	1		_aKimura, Hideki
700	1		_aArawaka, Shigeki
700	1		_aKawanami, Toru
700	1		_aKurita, Keiji
700	1		_aKadoya, Toshihiko
700	1		_aAoki, Masashi
700	1		_aItoyama, Yasuto
700	1		_aKato, Takeo
773	0		_tExperimental neurology _gvol. 194 _gno. 1 _gp. 203-11
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2005.02.011 _zAvailable from publisher's website
999			_c15561539 _d15561539